Trials / Withdrawn
WithdrawnNCT01623882
Clinical Evaluation of the Combined Use of Apligraf® and the SNaP® Pressure Wound Therapy System
Clinical Evaluation of the Combined Use of Apligraf® and the SNaP® Negative Pressure Wound Therapy System for Treatment of Non-responding Venous Stasis and Diabetic Lower Extremity Ulcers
- Status
- Withdrawn
- Phase
- —
- Study type
- Observational
- Enrollment
- 0 (actual)
- Sponsor
- KCI USA, Inc · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The primary purpose of this study is to evaluate the safety and efficacy of the concurrent use of Apligraf® and the SNaP® Wound Care System for the treatment of diabetic and venous stasis lower extremity ulcers.
Conditions
Timeline
- Start date
- 2012-06-01
- Primary completion
- 2014-06-01
- Completion
- 2015-12-01
- First posted
- 2012-06-20
- Last updated
- 2024-11-25
Source: ClinicalTrials.gov record NCT01623882. Inclusion in this directory is not an endorsement.